Human Neuron Transplants Treat Spinal Cord Injury in Mice
Chronic pain and loss of bladder control are among the most devastating consequences of spinal cord injury.
University of California San Francisco
Give to UCSF
‘Video Game’ More Accurate than Standard Tests at ID’ing Kids with Attention Deficits, Study Shows
A digital assessment platform designed to look and feel like a video game may successfully flag children with attention disorders.
The Race to Develop a Super Alarm to Combat Alarm Fatigue in ICUs
An interdisciplinary team of UCSF researchers, led by Xiao Hu, Michele Pelter and Richard Fidler from the UCSF School of Nursing, is working furiously to create and test a “super alarm.”
$85 Million Grant Supports UCSF Clinical and Translational Science Institute
UC San Francisco’s Clinical and Translational Science Institute (CTSI) has received $85 million over five years from the National Institutes of Health (NIH) to continue to provide training, research support and other services, and to launch new programs aimed at diversifying the patients in research and advancing precision medicine.
Researchers Map Zika’s Routes to the Developing Fetus
Zika virus can infect numerous cell types in the human placenta and amniotic sac, according to researchers at UCSF and UC Berkeley who show in a new paper how the virus travels from a pregnant woman to her fetus.
Popular Mobile Health Apps Fail to Serve Vulnerable Populations
A new UCSF study of top-rated mobile health apps showed that they offer little help to vulnerable patients – those who might benefit the most from these tools.
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer
Using advanced imaging technology that allowed them to spy on interactions among cells in the lymph nodes of living mice, a research team led by UCSF scientists has identified a cell that is a key player in mounting the immune system’s defense against cancer.
Decade After QB3’s First Incubator, Lawmaker Wants to Fund More UC Innovation
Ten years after the QB3 Garage incubator launched, the idea has grown an innovation ecosystem and become the catalyst for state legislation that could help turn ideas at UC campuses into job-providing companies.
UCSF Diabetes Center Forms Precision Medicine Initiative with Prevention Program, Yes Health
This week, the Diabetes Center at UCSF announced that it has embarked on a precision medicine initiative with Yes Health, an all-mobile program to prevent type 2 diabetes.
'Hey Siri, I’m Depressed': Can Smartphones Answer the Call for Help?
Personal voice assistants are increasingly used by smartphone owners for a range of health questions, but in a new study the telephone conversational agents responded inconsistently and incompletely to simple questions about mental health, rape and domestic violence.
Researchers Create Cellular “ORACLs” to Aid Drug Discovery
A team of researchers at UCSF has devised a new approach for early stage drug discovery that uses techniques from the world of computer vision in combination with a powerful new tool.
Big Ideas in Health and Science for 2016
We asked experts across UCSF to identify what's ahead in how we approach research, what disease areas will see major advances, and where basic science will be translating into real treatments.
Illuminating Depression’s Circuitry
If depression is caused by flawed brain circuitry, it may be possible to shift that circuitry toward healthy neural processing instead. UCSF researchers hope to map and correct aberrant neural behavior to cure mood disorders.
UCSF Awarded $9.75 Million to Create Platform Accelerating Mobile Health Research
Building on the success of the Health eHeart Study at UCSF, the National Institutes of Health has awarded $9.75 million to UCSF over the next five years for creation of Health ePeople.
Antibody Network Partners With Celgene for Cancer Therapies
A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN), a consortium comprising research groups from UCSF, the University of Chicago and the University of Toronto, will support the development of next-generation, antibody-based cancer therapies.